China Deal Monitor: Diagnostics firm GensKey raises $14m and other updates

China Deal Monitor: Diagnostics firm GensKey raises $14m and other updates

China’s genetic testing and medical diagnostic service provider GensKey has secured nearly 100 million yuan ($14 million) in a Series B round of financing from SB China Capital, Shanghai Lin Chong Investment Management, and Juyuan Capital. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter